UCB signs Parkinson’s research deal
October 12, 2010Research and Development Parkinson's, Synosia Therapeutics, UCB, neurology
UCB has partnered with Synosia Therapeutics to develop two of the Swiss firm’s compounds for Parkinson’s disease. Basel-based Synosia has …
Stem cell trial re-starts
October 12, 2010Research and Development Geron, Stem cells, spinal injury
Geron Corporation has enrolled the first patient in its restarted clinical trial of human embryonic stem cells (hESC). The world’s …
Making the most of outsourcing and offshoring
October 12, 2010Manufacturing and Production, Research and Development Kinapse, outsourcing
As the budgets of pharma companies face continued downward pressure, the objective of outsourcing is not only to find effective …
Merck will appeal EMA’s Movectro decision
October 12, 2010Sales and Marketing CHMP, EMA, Merck KGaA, Merck Serono, Movectro
Merck KGaA is poised to appeal the EMA’s decision on its MS treatment Movectro after the regulator rejected the drug …
UniversalProcon expands UK team
October 11, 2010Sales and Marketing UniversalProcon, appointment, sales and marketing
Transatlantic event management company UniversalProcon has expanded its UK operations with five new appointments. Sophie Limbert (pictured) joins as a …
ABPI’s Barker to step down
October 11, 2010Sales and Marketing ABPI, appointment, sales and marketing
ABPI director general Dr Richard Barker is to step down in 2011 after six years at the helm of the …
Abbott withdraws anti-obesity drug amid safety worries
October 11, 2010Sales and Marketing Abbott, Meridia, obesity
Abbott has pulled its anti-obesity drug Meridia in the US after recent trials showed it increased the risk of stroke …
Treasure trove of cancer information on tap for GPs
October 11, 2010Medical Communications Cancer, Doctors.net.uk, GP, cancer care, online community, professional network
Cancer Research UK appoints Doctors.net to launch campaign to raise awareness of the charity’s vast information resources for GPs
Boehringer pulls ‘Pink Viagra’
October 11, 2010Sales and Marketing Boehringer, Girosa
Boehringer Ingelheim has discontinued development of its hypoactive sexual desire disorder drug Girosa after the FDA refused to approve it. …
Sanofi slashes US workforce
October 11, 2010Sales and Marketing Sanofi-Aventis, job cuts
Sanofi-Aventis is to cut a quarter of its workforce in the US – making 1,700 people redundant – as it …
Novartis eyes genomics route for flu vaccines
October 11, 2010Manufacturing and Production, Research and Development Novartis, Synthetic Genomics Vaccines, genomics
Novartis will make use of a technology developed by Synthetic Genomics Vaccines, a new company set up by genomics pioneer …
Fleishman appoints Henry Featherstone
October 8, 2010Medical Communications Fleishman, appointment, medical communications
Henry Featherstone has joined Fleishman-Hillard’s London healthcare public affairs and corporate communications team as a senior policy adviser. He moves …
Digital Pharma: Facebook first from Janssen
October 8, 2010Medical Communications Digital Pharma blog, Facebook, Janssen, Twitter, ipad, iphone, youtube
Janssen UK has officially launched its new psoriasis disease awareness campaign, part of which includes the first pharma Facebook page …
NHS reforms moving ‘too fast’
October 8, 2010NHS, government, king's fund
The government’s plans to reform the NHS are moving too far according to health think tank the King’s Fund. Radical …
Novo Nordisk invests $73m to boost diabetes drug production
October 8, 2010Manufacturing and Production Novo Nordisk, diabetes, insulin
Novo Nordisk has announced another major expansion of its manufacturing capacity for diabetes products, setting aside $73 million to expand …
AZ plans heart attack study for Brilique
October 8, 2010Research and Development, Sales and Marketing AstraZeneca, Brilinta, Brilique
AstraZeneca is due to begin enrolling patients into a new study of its oral antiplatelet Brilique (ticagrelor) before the end …
Going Digital: Challenge your assumptions
October 8, 2010Medical Communications PraeMedica, digital, digital marketing, digital pharma
A wise man once said: “The secret to surviving is knowing what to throw away and knowing what to keep.” …
Battle for Alzheimer’s drugs finally over
October 8, 2010Sales and Marketing Alzheimer's, Aricept, NICE
NICE is to allow wider access to Alzheimer’s disease treatments, ending an epic five year battle for access to the …
Trio of appointments at 4Sight
October 7, 2010Sales and Marketing 4Sight, appointment, sales and marketing
Bracknell, UK-based Commercial services company 4Sight has made three high-level appointments. Jonathan Hartless (pictured) joins as operations director from an …
Avandia should still be on the market, says GSK
October 7, 2010Sales and Marketing Avandia, GlaxoSmithKline
GlaxoSmithKline believes European regulators were wrong to withdraw its diabetes drug Avandia from the market, but will not challenge their …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
